Literature DB >> 23949949

Clinical management of resistant hypertension: practical recommendations from the Italian Society of Hypertension (SIIA).

Franco Veglio1, Guido Grassi, Giuseppe Mancia, Massimo Volpe.   

Abstract

According to recent hypertension guidelines, resistant hypertension is a clinical condition characterized by the presence of BP values above the recommended limits of the reference values (BP >140/90 mmHg). The prevalence of this clinical condition is about 10 % of the essential hypertensives. A proper diagnosis and management of resistant hypertension should go trough careful, mandatory clinical step, aimed at excluding the presence of pseudo-resistance hypertension. In this report, we summarized the practical recommendations are targeting both the general practitioner and the specialist who play an active role in the clinical management of patients with arterial hypertension.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23949949     DOI: 10.1007/s40292-013-0022-3

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  28 in total

1.  Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial.

Authors:  Suzanne Oparil; Steven A Yarows; Samir Patel; Hui Fang; Jack Zhang; Andrew Satlin
Journal:  Lancet       Date:  2007-07-21       Impact factor: 79.321

2.  Shattuck Lecture. The hypertension paradox--more uncontrolled disease despite improved therapy.

Authors:  Aram V Chobanian
Journal:  N Engl J Med       Date:  2009-08-27       Impact factor: 91.245

Review 3.  Challenging hypertension: how to diagnose and treat resistant hypertension in daily clinical practice.

Authors:  Massimo Volpe; Giuliano Tocci
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-06

Review 4.  Resistant hypertension and left ventricular hypertrophy: an overview.

Authors:  Cesare Cuspidi; Alvaro Vaccarella; Francesca Negri; Carla Sala
Journal:  J Am Soc Hypertens       Date:  2010 Nov-Dec

5.  ESH position paper: renal denervation - an interventional therapy of resistant hypertension.

Authors:  Roland E Schmieder; Josep Redon; Guido Grassi; Sverre E Kjeldsen; Giuseppe Mancia; Krzysztof Narkiewicz; Gianfranco Parati; Luis Ruilope; Philippe van de Borne; Costas Tsioufis
Journal:  J Hypertens       Date:  2012-05       Impact factor: 4.844

6.  Prognostic significance of a reduced glomerular filtration rate and interaction with microalbuminuria in resistant hypertension: a cohort study.

Authors:  Gil F Salles; Claudia R L Cardoso; Vinicius S Pereira; Roberto Fiszman; Elizabeth S Muxfeldt
Journal:  J Hypertens       Date:  2011-10       Impact factor: 4.844

7.  2012 consensus document of the Italian Society of Hypertension (SIIA): strategies to improve blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy.

Authors:  Massimo Volpe; Enrico Agabiti Rosei; Ettore Ambrosioni; Santina Cottone; Cesare Cuspidi; Claudio Borghi; Nicola De Luca; Francesco Fallo; Claudio Ferri; Alberto Morganti; Maria Lorenza Muiesan; Riccardo Sarzani; Leonardo Sechi; Agostino Virdis; Giuliano Tocci; Bruno Trimarco; Alessandro Filippi; Giuseppe Mancia
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-03-28

8.  Blood pressure control in Italy: results of recent surveys on hypertension.

Authors:  Massimo Volpe; Giuliano Tocci; Bruno Trimarco; Enrico Agabiti Rosei; Claudio Borghi; Ettore Ambrosioni; Alessandro Menotti; Alberto Zanchetti; Giuseppe Mancia
Journal:  J Hypertens       Date:  2007-07       Impact factor: 4.844

9.  Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial.

Authors:  Neil Chapman; Choon Lan Chang; Björn Dahlöf; Peter S Sever; Hans Wedel; Neil R Poulter
Journal:  Circulation       Date:  2008-06-16       Impact factor: 29.690

10.  Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension.

Authors:  Jens Jordan; Volkan Yumuk; Markus Schlaich; Peter M Nilsson; Barbara Zahorska-Markiewicz; Guido Grassi; Roland E Schmieder; Stefan Engeli; Nick Finer
Journal:  J Hypertens       Date:  2012-06       Impact factor: 4.844

View more
  5 in total

1.  Prevalence and Comorbidities of Resistant Hypertension: A Collaborative Population-Based Observational Study.

Authors:  Simone Romano; Chiara Idolazzi; Cristiano Fava; Luigi Fondrieschi; Mario Celebrano; Pietro Delva; Lorella Branz; Angela Donato; Andrea Dalbeni; Pietro Minuz
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-06-29

2.  National Cross-Sectional Survey on Blood Pressure: A Gateway to a Better Appraisal of Hypertension in the Young.

Authors:  Massimo Volpe; Claudio Borghi
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-04-27

Review 3.  Resistant Hypertension: An Incurable Disease or Just a Challenge For Our Medical Skill?

Authors:  Marina Di Pilla; Rosa Maria Bruno; Stefano Taddei
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-05-17

4.  Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers: results from the MINISAL-SIIA study program.

Authors:  F Galletti; A Barbato
Journal:  J Hum Hypertens       Date:  2016-03-03       Impact factor: 3.012

5.  National survey on excellence centers and reference centers for hypertension diagnosis and treatment: geographical distribution, medical facilities and diagnostic opportunities.

Authors:  Giuliano Tocci; Nicola De Luca; Riccardo Sarzani; Ettore Ambrosioni; Claudio Borghi; Santina Cottone; Cesare Cuspidi; Francesco Fallo; Claudio Ferri; Alberto Morganti; Maria Lorenza Muiesan; Leonardo Sechi; Agostino Virdis; Giuseppe Mancia; Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-11-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.